Congress of the European Society of Cardiology (Barcelona, 2017): Results of the Most Important Clinical Trials
https://doi.org/10.18087/cardio.2018.11.10208
Abstract
A report was presented on all four Hot Line: Late-Breaking Clinical Trials sessions of the European Society of Cardiology Congress 2017 on the results of new clinical research in cardiology.
About the Authors
S. G. Kanorskii
Kuban State Medical University
Russian Federation
Russian Federation
Kanorskii Sergey G. - MD, professor.
Krasnodar
M. N. Mamedov
National Research Center for Preventive Medicine
Russian Federation
Russian Federation
Moscow
R. G. Oganov
National Research Center for Preventive Medicine
Russian Federation
Russian Federation
Moscow
References
1. Eikelboom J. W., Connolly S.J., Bosch J. et al. Rivaroxaban with or without Aspirin in Stable Cardiovascular Disease. N Engl J Med 2017 Aug 27. [Epub ahead of print].
2. Ridker P. M., Everett B. M., Thuren T. et al. Antiinflammatory Therapy with Canakinumab for Atherosclerotic Disease. N Engl J Med 2017;377 (12):1П9-Ш1.
3. Townsend R. R., Mahfoud F., Kandzari D. E. et al. Catheter-based renal denervation in patients with uncontrolled hypertension in the absence of antihypertensive medications (SPYRAL HTN-OFF MED): a randomised, sham-controlled, proof-of-concept trial. Lancet. 2017 Aug 25. [Epub ahead of print].
4. Vinereanu D., Lopes R. D., Bahit M. C. et al. A multifaceted intervention to improve treatment with oral anticoagulants in atrial fibrillation (IMPACT-AF): an international, cluster-randomised trial. Lancet 2017 Aug 25. [Epub ahead of print].
5. Lindholt J. S., Sogaard R. Population screening and intervention for vascular disease in Danish men (VIVA): a randomised controlled trial. Lancet 2017 Aug 25. [Epub ahead of print].
6. Ray K. K., Landmesser U., Leiter L. A. et al. Inclisiran in Patients at High Cardiovascular Risk with Elevated LDL Cholesterol. N Engl J Med 2017;376 (15):1430-1440.
7. Hofmann R., James S. K., Jernberg T. et al. Oxygen Therapy in Suspected Acute Myocardial Infarction. N Engl J Med 2017;377 (13):1240-1249.
8. Ference B. A., Kastelein J.J. P., Ginsberg H. N. et al. Association of Genetic Variants Related to CETP Inhibitors and Statins With Lipoprotein Levels and Cardiovascular Risk. JAMA 2017;318 (10):947-956.
9. Ruschitzka F., Borer J. S., Krum H. et al. Differential Blood Pressure Effects of Ibuprofen, Naproxen, and Celecoxib in Patients With Arthritis Eur Heart J 2017 Aug 28. [Epub ahead of print].
10. HPS3/TIMI55-REVEAL Collaborative Group. Effects of Anace-trapib in Patients with Atherosclerotic Vascular Disease. N Engl J Med 2017;377 (13):1217-1227.
Review
For citations:
Kanorskii S.G., Mamedov M.N., Oganov R.G. Congress of the European Society of Cardiology (Barcelona, 2017): Results of the Most Important Clinical Trials. Kardiologiia. 2018;58(11):35-40. (In Russ.) https://doi.org/10.18087/cardio.2018.11.10208
Views:
945
Email this article 
Post a Comment 
